UK charity invests £1 million to develop potential therapeutic for Parkinson’s

UK charity invests £1 million to develop potential therapeutic for Parkinson’s
Charity Parkinson's UK is partnering with NRG Therapeutics Ltd to discover and develop a potential drug that could safeguard dopamine cells that are damaged by Parkinson's and slow down the progression of the condition. ... read more
Source: News-Medical.NetPublished on 2019-07-01